Bleichroeder LP - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 54 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bleichroeder LP ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$52,625
+31.6%
250,0000.0%0.01%
+22.2%
Q1 2023$40,000
-71.2%
250,0000.0%0.01%
-70.0%
Q4 2022$138,750
-53.4%
250,0000.0%0.03%
-51.6%
Q3 2022$298,000
+88.6%
250,0000.0%0.06%
+87.9%
Q2 2022$158,000
-44.6%
250,0000.0%0.03%
-35.3%
Q1 2022$285,000
-49.4%
250,0000.0%0.05%
-42.0%
Q4 2021$563,000
-34.2%
250,0000.0%0.09%
-36.7%
Q3 2021$855,000
+14.3%
250,0000.0%0.14%
+23.0%
Q2 2021$748,000
-53.7%
250,000
-50.0%
0.11%
-18.1%
Q1 2021$1,616,000
+204.9%
500,000
+100.0%
0.14%
+34.0%
Q4 2020$530,000
+81.5%
250,0000.0%0.10%
+98.1%
Q3 2020$292,000
+29.2%
250,0000.0%0.05%
+30.0%
Q2 2020$226,000
-46.1%
250,000
-50.0%
0.04%
-63.6%
Q1 2020$419,000
-12.7%
500,0000.0%0.11%
+44.7%
Q4 2019$480,000500,0000.08%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
BVF INC/IL 9,766,508$19,826,0002.39%
PLATINUM INVESTMENT MANAGEMENT LTD 1,286,032$2,610,0000.07%
Clear Harbor Asset Management, LLC 153,800$312,0000.06%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 219,652$445,0000.03%
Rock Springs Capital Management LP 270,000$548,0000.02%
Alambic Investment Management, L.P. 77,665$158,0000.02%
Marshall Wace North America L.P. 1,173,515$2,382,0000.01%
Baker Brothers Advisors 580,400$1,178,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 459,000$932,0000.01%
Intellectus Partners, LLC 13,000$26,0000.01%
View complete list of INFINITY PHARMACEUTICALS INC shareholders